期刊文献+

HIV/AIDS病人HBV HCV梅毒感染率的调查分析 被引量:24

Prevalence of HIV/HBV,HIV/HCV and HIV/syphilis co-infections
原文传递
导出
摘要 目的通过回顾性研究,了解艾滋病病毒(HIV)感染者/艾滋病(AIDS)病人(简称HIV/AIDS病人)乙型肝炎(简称乙肝)病毒(HBV)、丙型肝炎(简称丙肝)病毒(IHCV)、梅毒的感染率及乙肝病毒表面抗体(HBsAb)的阳性率,为预防HIV/AIDS病人发生合并感染提供理论依据。方法 2014年8月1日至2015年7月31日,对在北京地坛医院皮肤科门诊开始抗病毒治疗的1 010例成年HIV/AIDS病人,收集基线的人口学资料和临床资料,使用描述性统计学方法分析HIV/AIDS病人HBV、HCV和梅毒的感染率。结果 1 010例HIV/AIDS病人的年龄中位数为29(26~37)岁,96.14%(971例)为男性,91.39%(923例)的病人通过性途径感染HIV。931例病人在基线检测了乙肝病毒表面抗原(HBsAg),阳性率为6.55%(61例)。918例病人在基线检测了HBsAb,阳性率为58.71%(539例),28.98%(266例)病人HBsAb的数值>100 mIU/mI。921例病人检测了抗-HCV,阳性率为2.28%(21例)。870例病人进行了甲苯胺红不加热血清试验(TRUST),阳性率为24.48%(213例)。男性HIV/AIDS病人合并梅毒的感染率比女性高(P=0.043),70.42%(150/213)的HI+V/梅毒病人TRUST的滴度≥1:4。结论HIV/AIDS病人合并I-IBV感染率相对较高,HBsAb阳性率低,在适当的时机应进行乙肝疫苗的接种或补种。虽然HIV/AIDS病人合并HCV感染率相对比较低,但这部分人群依旧是存在的,必要的时候应建议启动丙肝的治疗。HIV/AIDS病人合并梅毒感染率很高,临床医生在工作中应向病人宣传如何有效地预防性传播疾病,即使高效抗病毒治疗后,HIV核糖核酸处于检测下限,HIV/AIDS病人也应使用安全套。 Objective To retrospectively study the prevalence of human immunodeficiency virus(HIV)/hepatitis B virus(HBV),HIV/hepatitis C virus(HCV) and HIV/syphilis co-infections and HBsAb positive in HIV/AIDS patients.Methods Baseline demographic and clinical data of 1010 HAART-naive HIV-infected patients were collected from August 1,2014 to July 31,2015 in Beijing Ditan hospital.The prevalence of HIV/HBV,HIV/HCV and HIV/syphilis co-infections were analyzed with descriptive methods.Results 1010 HIV/acquired immune deficiency syndrome(AIDS) HAART naive patients participated in the study.Their median age was 29 years old,with 96.14%male.931 patients was detected for hepatitis B surface antibody(HBsAg),with 6.55%(61/931) of HBsAg-positive.918 patients was detected for HBsAb,with 58.71%(539/918) of HBsAb-positive,and 28.98%(266/918) were more than 100 mIU/mL.921 patients was detected for anti-HCV antibody,with2.28%(21/921) of anti-HCV-positive.870 patients was detected for TRUST,with 24.48%(213/870) of TRUST-positive,and prevalence of HIV/syphilis co-infected male patients was higher than that of female patients(P=0.043).TRUST titer of 150 HIV/syphilis co-infected patients was more than 1:4(70.42%).Conclusion The prevalence of HIV/HBV co-infected patients is relatively high,and that of HBsAb positive is relatively low,indicating that HBV vaccination is necessary for HIV(+)/HBsAg(-) patients with lower titer of HBsAb.We also find higher prevalence of HIV/syphilis co-infection,suggesting that the patients should know how to effectively prevent themselves from sexually transmitted diseases.We also find low prevalence of HIV/HCV coinfected patients,who should take HCV antiviral therapy.
作者 徐玲 戴国瑞 种雪静 汪笛 肖江 郜桂菊 杨涤 赵红心 Xu Ling Dai Guorui Chong Xuejing Wang Di Xiao JiangI Gao Guiju Yang Di Zhao Hongxin(Beijing Ditan Hospital, Capital Medi- cal University, Beijing 100015 ,China Peking University Ditan Teaching Hospital)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2017年第2期138-141,共4页 Chinese Journal of Aids & STD
基金 美国NH项目(2R01MH083552-06A1) 国家自然科学基金(81371804) 2014年首都卫生发展科研专项项目(2014-2-2173) 北京市科学技术委员会HIV/HBV共感染研究项目(D161100000416004) 感染病科国家临床重点专科建设项目~~
  • 相关文献

同被引文献229

引证文献24

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部